Cyclodextrins in delivery systems: Applications

Gaurav Tiwari

Journal of Pharmacy And Bioallied Sciences · 2010 · 434 citations · 56 references

DOIFull text

Open access

Concepts

TL;DR

Cyclodextrins are cyclic oligosaccharides with a hydrophilic exterior and lipophilic cavity that, due to their size and hydrogen‑bonding capacity, generally do not permeate lipophilic membranes but are widely used as complexing agents to enhance solubility, bioavailability, and stability of poorly soluble drugs, with roughly 30 drug/CD products on the market. The paper reviews current CD‑based therapeutics and explores future applications, particularly the use of CD‑containing polymers for nucleic acid delivery. The authors review CD‑containing polymers and their application in drug delivery systems. Human and animal studies demonstrate that CDs can enhance drug delivery across a wide range of formulations.

Abstract

Cyclodextrins (CDs) are a family of cyclic oligosaccharides with a hydrophilic outer surface and a lipophilic central cavity. CD molecules are relatively large with a number of hydrogen donors and acceptors and, thus in general, they do not permeate lipophilic membranes. In the pharmaceutical industry, CDs have mainly been used as complexing agents to increase aqueous solubility of poorly soluble drugs and to increase their bioavailability and stability. CDs are used in pharmaceutical applications for numerous purposes, including improving the bioavailability of drugs. Current CD-based therapeutics is described and possible future applications are discussed. CD-containing polymers are reviewed and their use in drug delivery is presented. Of specific interest is the use of CD-containing polymers to provide unique capabilities for the delivery of nucleic acids. Studies in both humans and animals have shown that CDs can be used to improve drug delivery from almost any type of drug formulation. Currently, there are approximately 30 different pharmaceutical products worldwide containing drug/CD complexes in the market.

References

56